semaglutide or tirzepatide for inflammation Frontiers Semaglutide and Tirzepatide are often

Diabetes Obes Metab 20(4):985997

While some trials show no major changes in BMD, others suggest slight improvements in bone turnover markers: Trials of liraglutide and exenatide generally show stable BMD over 612 months Certain populations such as postmenopausal women or individuals with rapid weight loss may show changes in bone markers like osteocalcin and P1NP However, most of these studies are small, short-term, or not powered for skeletal endpoints

A p -value 0.05)

Ensure you get adequate rest and engage in relaxation techniques, such as deep breathing or yoga, to help manage stress and enhance your overall well-being

Some people continue feeling reduced hunger for weeks after stopping treatment, while others notice their appetite returning much sooner